Biopoin

Land: Europeiska unionen

Språk: engelska

Källa: EMA (European Medicines Agency)

Köp det nu

Bipacksedel Bipacksedel (PIL)
27-09-2023
Produktens egenskaper Produktens egenskaper (SPC)
27-09-2023

Aktiva substanser:

epoetin theta

Tillgänglig från:

Teva GmbH

ATC-kod:

B03XA01

INN (International namn):

epoetin theta

Terapeutisk grupp:

Other antianemic preparations

Terapiområde:

Kidney Failure, Chronic; Anemia; Cancer

Terapeutiska indikationer:

Treatment of symptomatic anaemia associated with chronic renal failure in adult patients.Treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.

Produktsammanfattning:

Revision: 15

Bemyndigande status:

Authorised

Tillstånd datum:

2009-10-23

Bipacksedel

                                54
B. PACKAGE LEAFLET
55
PACKAGE LEAFLET: INFORMATION FOR THE USER
BIOPOIN 1,000 IU/0.5 ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
BIOPOIN 2,000 IU/0.5 ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
BIOPOIN 3,000 IU/0.5 ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
BIOPOIN 4,000 IU/0.5 ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
BIOPOIN 5,000 IU/0.5 ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
BIOPOIN 10,000 IU/1 ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
BIOPOIN 20,000 IU/1 ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
BIOPOIN 30,000 IU/1 ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
epoetin theta
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Biopoin is and what it is used for
2.
What you need to know before you use Biopoin
3.
How to use Biopoin
4.
Possible side effects
5.
How to store Biopoin
6.
Contents of the pack and other information
7.
Information for injecting yourself
1.
WHAT BIOPOIN IS AND WHAT IT IS USED FOR
WHAT BIOPOIN IS
Biopoin contains the active substance epoetin theta, which is almost
identical to erythropoietin, a
natural hormone produced by your body. Epoetin theta is a protein
produced by biotechnology. It
works in exactly the same way as erythropoietin. Erythropoietin is
produced in your kidneys and
stimulates your bone marrow to produce red blood cells. Red blood
cells are very important for
distributing oxygen within your body.
WHAT BIOPOIN IS USED FOR
Biopoin is used for the treatment of anaemia accompanied by symptoms
(for example 
                                
                                Läs hela dokumentet
                                
                            

Produktens egenskaper

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Biopoin 1,000 IU/0.5 ml solution for injection in pre-filled syringe
Biopoin 2,000 IU/0.5 ml solution for injection in pre-filled syringe
Biopoin 3,000 IU/0.5 ml solution for injection in pre-filled syringe
Biopoin 4,000 IU/0.5 ml solution for injection in pre-filled syringe
Biopoin 5,000 IU/0.5 ml solution for injection in pre-filled syringe
Biopoin 10,000 IU/1 ml solution for injection in pre-filled syringe
Biopoin 20,000 IU/1 ml solution for injection in pre-filled syringe
Biopoin 30,000 IU/1 ml solution for injection in pre-filled syringe
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Biopoin 1,000 IU/0.5 ml solution for injection in pre-filled syringe
One pre-filled syringe contains 1,000 international units (IU) (8.3
µg) epoetin theta in 0.5 ml solution
for injection corresponding to 2,000 IU (16.7 µg) epoetin theta per
ml.
Biopoin 2,000 IU/0.5 ml solution for injection in pre-filled syringe
One pre-filled syringe contains 2,000 international units (IU) (16.7
µg) epoetin theta in 0.5 ml solution
for injection corresponding to 4,000 IU (33.3 µg) epoetin theta per
ml.
Biopoin 3,000 IU/0.5 ml solution for injection in pre-filled syringe
One pre-filled syringe contains 3,000 international units (IU) (25
µg) epoetin theta in 0.5 ml solution
for injection corresponding to 6,000 IU (50 µg) epoetin theta per ml.
Biopoin 4,000 IU/0.5 ml solution for injection in pre-filled syringe
One pre-filled syringe contains 4,000 international units (IU) (33.3
µg) epoetin theta in 0.5 ml solution
for injection corresponding to 8,000 IU (66.7 µg) epoetin theta per
ml.
Biopoin 5,000 IU/0.5 ml solution for injection in pre-filled syringe
One pre-filled syringe contains 5,000 international units (IU) (41.7
µg) epoetin theta in 0.5 ml solution
for injection corresponding to 10,000 IU (83.3 µg) epoetin theta per
ml.
Biopoin 10,000 IU/1 ml solution for injection in pre-filled syringe
One pre-filled syringe contains 10,000 international units (IU) (8
                                
                                Läs hela dokumentet
                                
                            

Dokument på andra språk

Bipacksedel Bipacksedel bulgariska 27-09-2023
Produktens egenskaper Produktens egenskaper bulgariska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport bulgariska 16-12-2009
Bipacksedel Bipacksedel spanska 27-09-2023
Produktens egenskaper Produktens egenskaper spanska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport spanska 16-12-2009
Bipacksedel Bipacksedel tjeckiska 27-09-2023
Produktens egenskaper Produktens egenskaper tjeckiska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport tjeckiska 16-12-2009
Bipacksedel Bipacksedel danska 27-09-2023
Produktens egenskaper Produktens egenskaper danska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport danska 16-12-2009
Bipacksedel Bipacksedel tyska 27-09-2023
Produktens egenskaper Produktens egenskaper tyska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport tyska 16-12-2009
Bipacksedel Bipacksedel estniska 27-09-2023
Produktens egenskaper Produktens egenskaper estniska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport estniska 16-12-2009
Bipacksedel Bipacksedel grekiska 27-09-2023
Produktens egenskaper Produktens egenskaper grekiska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport grekiska 16-12-2009
Bipacksedel Bipacksedel franska 27-09-2023
Produktens egenskaper Produktens egenskaper franska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport franska 16-12-2009
Bipacksedel Bipacksedel italienska 27-09-2023
Produktens egenskaper Produktens egenskaper italienska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport italienska 16-12-2009
Bipacksedel Bipacksedel lettiska 27-09-2023
Produktens egenskaper Produktens egenskaper lettiska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport lettiska 16-12-2009
Bipacksedel Bipacksedel litauiska 27-09-2023
Produktens egenskaper Produktens egenskaper litauiska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport litauiska 16-12-2009
Bipacksedel Bipacksedel ungerska 27-09-2023
Produktens egenskaper Produktens egenskaper ungerska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport ungerska 16-12-2009
Bipacksedel Bipacksedel maltesiska 27-09-2023
Produktens egenskaper Produktens egenskaper maltesiska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport maltesiska 16-12-2009
Bipacksedel Bipacksedel nederländska 27-09-2023
Produktens egenskaper Produktens egenskaper nederländska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport nederländska 16-12-2009
Bipacksedel Bipacksedel polska 27-09-2023
Produktens egenskaper Produktens egenskaper polska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport polska 16-12-2009
Bipacksedel Bipacksedel portugisiska 27-09-2023
Produktens egenskaper Produktens egenskaper portugisiska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport portugisiska 16-12-2009
Bipacksedel Bipacksedel rumänska 27-09-2023
Produktens egenskaper Produktens egenskaper rumänska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport rumänska 16-12-2009
Bipacksedel Bipacksedel slovakiska 27-09-2023
Produktens egenskaper Produktens egenskaper slovakiska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport slovakiska 16-12-2009
Bipacksedel Bipacksedel slovenska 27-09-2023
Produktens egenskaper Produktens egenskaper slovenska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport slovenska 16-12-2009
Bipacksedel Bipacksedel finska 27-09-2023
Produktens egenskaper Produktens egenskaper finska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport finska 16-12-2009
Bipacksedel Bipacksedel svenska 27-09-2023
Produktens egenskaper Produktens egenskaper svenska 27-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport svenska 16-12-2009
Bipacksedel Bipacksedel norska 27-09-2023
Produktens egenskaper Produktens egenskaper norska 27-09-2023
Bipacksedel Bipacksedel isländska 27-09-2023
Produktens egenskaper Produktens egenskaper isländska 27-09-2023
Bipacksedel Bipacksedel kroatiska 27-09-2023
Produktens egenskaper Produktens egenskaper kroatiska 27-09-2023

Sök varningar relaterade till denna produkt

Visa dokumenthistorik